PART I . Overview We are a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes. Founded in 2018, atai emerged from the urgent need for better mental health solutions for patients who are under-served by current treatment options. We are advancing a pipeline of product candidates designed to address the complex nature of mental health disorders. We believe that these investigational compounds have the potential t...
Q2 FY2026 — expected 2026-09-21
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-03-17 | 2024-12-31 | 0000950170-25-040244 | EDGAR | 146K words |
| 2024-03-28 | 2023-12-31 | 0000950170-24-038138 | EDGAR | — |
| 2023-03-24 | 2022-12-31 | 0000950170-23-009756 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0000950170-22-005013 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001193125-25-277583 | EDGAR | 57K words |
| 2025-08-14 | 2025-06-30 | 0000950170-25-108883 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0000950170-25-071435 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0000950170-24-126515 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0000950170-24-096296 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0000950170-24-060044 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0000950170-23-063730 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041345 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021271 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024162 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0000950170-22-017253 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0000950170-22-009966 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-12-05 | 0001140361-25-044579 | EDGAR | 4K words |
| 2025-11-12 | 0001140361-25-041546 | EDGAR | — |
| 2025-11-05 | 0001140361-25-040444 | EDGAR | — |
| 2025-11-05 | 0001140361-25-040429 | EDGAR | — |
| 2025-11-04 | 0001140361-25-040358 | EDGAR | — |
| 2025-10-27 | 0001140361-25-039317 | EDGAR | — |
| 2025-10-21 | 0001140361-25-038748 | EDGAR | — |
| 2025-10-20 | 0001140361-25-038525 | EDGAR | — |
| 2025-10-16 | 0001140361-25-038319 | EDGAR | — |
| 2025-10-10 | 0001140361-25-037941 | EDGAR | — |
99 total filings indexed. 73 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001840904 |
| Ticker | ATAI |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | P7 |
| Website | https://www.ataibeckley.com |
| Listed | 2021-06-18 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report